Abstract
Background
Lung cancer is the primary cause of cancer-related mortality worldwide. Hemoglobin (Hb) represents the most widely utilized test parameter in clinical settings. However, few articles have examined the causal relationship between Hb concentration and lung cancer incidence.
Methods
Mendelian randomization (MR) was first conducted to investigate the potential causality between Hb and lung cancer. Sensitivity analyses were applied to validate the reliability of MR results. Then, the National Health and Nutrition Examination Survey (NHANES) database was used to verify the effect of Hb on the prognosis of lung cancer.
Results
The MR analysis demonstrated that Hb was casually associated with the decreased risk of lung cancer in the European population (ORIVW 0.84, 95% CI 0.75–0.95, p = 0.006; ORWeighted-median 0.78, 95% CI 0.65–0.94, p = 0.008; ORMR-Egger 0.82, 95% CI 0.64–1.04, p = 0.11). The results from the NHANES database showed that a high value of Hb was associated with better outcomes for patients with lung cancer (HR 0.45, 95% CI 0.26–0.79, p = 1.6E−03).
Conclusions
Our study provides further evidence for the relationship between Hb levels and lung cancer, highlighting the potential significance of Hb as a biomarker for predicting the risk and prognosis of lung cancer.
Similar content being viewed by others
Data availability statement
The original data are available in the published GWASs and NHANES database (https://www.cdc.gov/nchs/nhanes).
References
Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299–311. https://doi.org/10.1016/S0140-6736(16)30958-8.
Chen C, Song Z, Wang W, Zhou J. Baseline anemia and anemia grade are independent prognostic factors for stage IV non-small cell lung cancer. Mol Clin Oncol. 2021;14(3):59. https://doi.org/10.3892/mco.2021.2221.
Qu X, Zhang T, Ma H, Sui P, Du J. Lower mean corpuscular hemoglobin concentration is associated with unfavorable prognosis of resected lung cancer. Future Oncol. 2014;10(14):2149–59. https://doi.org/10.2217/fon.14.121.
Manegold C. The causes and prognostic significance of low hemoglobin levels in tumor patients. Strahlenther Onkol. 1998;174(Suppl 4):17–9.
Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10(4):486–96. https://doi.org/10.1002/jrsm.1346.
Birney E. Mendelian randomization. Cold Spring Harb Perspect Med. 2022;12(4):a041302. https://doi.org/10.1101/cshperspect.a041302.
Vaucher J, Keating BJ, Lasserre AM, Gan W, Lyall DM, Ward J, et al. Cannabis use and risk of schizophrenia: a Mendelian randomization study. Mol Psychiatry. 2018;23(5):1287–92. https://doi.org/10.1038/mp.2016.252.
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014;46(7):736–41. https://doi.org/10.1038/ng.3002.
Zhang YH, Lu Y, Lu H, Zhang MW, Zhou YM, Li XL, et al. Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer. Mol Clin Oncol. 2018;9(1):44–9. https://doi.org/10.3892/mco.2018.1628.
García Prim JM, González Barcala FJ, Moldes Rodríguez M, Alvarez Dobañob JM, Hervada Vidal X, Pose Reino A, et al. Impact of hemoglobin level on lung cancer survival. Med Clin (Barc). 2008;131(16):601–4. https://doi.org/10.1157/13127916.
Qureshi N, Orimoloye H, Hansen J, Saechao C, Olsen J, Federman N, et al. Maternal anemia and childhood cancer: a population-based case-control study in Denmark. Cancer Epidemiol. 2023;82:102308. https://doi.org/10.1016/j.canep.2022.102308.
Orimoloye HT, Qureshi N, Lee PC, Wu CK, Saechao C, Federman N, et al. Maternal anemia and the risk of childhood cancer: a population-based cohort study in Taiwan. Pediatr Blood Cancer. 2023;70(3):e30188. https://doi.org/10.1002/pbc.30188.
Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24. https://doi.org/10.1016/j.ccm.2019.10.001.
Ciaccio C, Coletta A, Coletta M. Role of hemoglobin structural-functional relationships in oxygen transport. Mol Aspects Med. 2022;84:101022. https://doi.org/10.1016/j.mam.2021.101022.
Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268–83. https://doi.org/10.1038/s41580-020-0227-y.
Chouaib S, Noman MZ, Kosmatopoulos K, Curran MA. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer. Oncogene. 2017;36(4):439–45. https://doi.org/10.1038/onc.2016.225.
Qu J, Guo X, Li W, Hou W, Zhang H, Luo L, et al. Preparation of artificial red cell and its application on alleviation of tumor hypoxia. Colloids Surf B Biointerfaces. 2017;160:446–54. https://doi.org/10.1016/j.colsurfb.2017.09.039.
Acknowledgements
We appreciate the participating patients in public databases for their contributions.
Funding
This work was supported by the Natural Science Foundation of Guangdong Province (2021A1515010480 to YB. Zhou).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study’s conception and design. Material preparation, data collection and analysis were performed by PD, WL, JD, LH, BL, SW, XX, YS, ZL, SL, JG, YQ and YZ. The first draft of the manuscript was written by PD, WL and JD. Funding acquisition, project administration, supervision and validation were performed by YZ. All authors commented on previous versions of the manuscript and read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
No ethics approval and written consent were needed for the secondary analysis of public data.
Informed consent
No informed consent were needed for the secondary analysis of public data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dong, P., Li, W., Deng, J. et al. Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey. Clin Transl Oncol 26, 623–629 (2024). https://doi.org/10.1007/s12094-023-03281-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-023-03281-8